All news

Raymond James sets USD 39.00 target for Acadia Healthcare stock

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Raymond James has initiated coverage on Acadia Healthcare (ACHC) with an Outperform rating and a $39.00 price target, implying a significant upside from its current Nasdaq price. This valuation comes as Acadia Healthcare reported strong second-quarter revenues, exceeding analyst expectations. The company is set to release its third-quarter results on November 4, 2026.

Read original source

ACHC company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.